Status:
RECRUITING
A Registry Study of Biomarkers in Ischemic Heart Disease ( BIOMS-IHD )
Lead Sponsor:
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Collaborating Sponsors:
Beijing Luhe Hospital
The First Affiliated Hospital of Shanxi Medical University
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
18-80 years
Brief Summary
The registry study aims to discover biomarkers for accurate classification and risk assessment of ischemic heart disease.
Detailed Description
The purpose of this study is to discover biomarkers for early identification, diagnosis, molecular classification, and intervention based on the mechanism of ischemic heart disease（IHD）. Using mass sp...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- Aged 18 years or older.
- Previous ischemic symptoms/signs or electrocardiographic ischemic changes and.
- \>70% stenosis of at least one epicardial coronary artery on angiography or a history of myocardial infarction or coronary revascularization.
- Exclusion Criteria:
- Current known inability to follow instructions or comply with follow-up procedures.
- Eligible patients without informed consent form
Exclusion
Key Trial Info
Start Date :
June 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT05965882
Start Date
June 1 2016
End Date
June 1 2024
Last Update
January 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China, 100029